10 November 2022
New partnership brings accurate trial recommendations to Azra AI’s national client base of medical systems and hospitals, including leading healthcare providers.
27 September 2022
Cancer death rates in the United States have been experiencing a steady decline, dropping 2.3% per year every year from 2016 through 2019, according to a new report from the American Association for Cancer Research (AACR).
06 July 2022
Now in use in more than 200 medical systems and hospitals across the country, Azra AI's technology helps clinicians and medical teams identify suspicious findings that could lead to an earlier cancer diagnosis for patients, where treatment options allow patients to potentially be cured. These findings are detected in patients that receive imaging primarily for other healthcare illnesses or conditions, which explains the term "incidental." Azra AI's technology identifies cancers that often have no symptoms until the cancer is late stage.
28 April 2022
Seasoned healthcare executive Brook Blackmore has joined the leadership team of Azra AI, a company whose technology identifies positive cancer diagnoses and incidental findings in real-time with an eye toward helping patients and clinicians.
28 April 2022
For most people, the shock of a cancer diagnosis quickly gives way to an action plan — disease research, doctor appointments, treatment options, and support outlets. But many patients are not able to take these steps or advocate for themselves. Some simply don't know how to move forward, which results in more complicated and expensive care, reduced life expectancies, and inferior health outcomes.
14 March 2022
The CEO said the acquisition from Smarsh, which closed in January on undisclosed terms, was made by Azra's owner, Invenero Health LLC. Invenero was registered in Delaware the same day as Invenero Holdings Inc., VNC research shows.